PRODUCT CATEGORIES

Product Advice




Home » Product » Bio-therapy system » Photopherasis » Photopherasis

Photopherasis

Extracorporeal Photopheresis (ECP) has been recognised by the scientific community as a therapeutic option to treat various disorders, such as:

  • Cutaneous T-cell lymphoma (Sezary syndrome)
  • GVHD (acute and chronic)
  • Solid organ transplant rejection

Macopharma has developed a complete product range for the off-line extracorporeal photpheresis technique.

Extracorporeal photopheresis (ECP) is based on the exposure of peripheral blood mononuclear cells to the photosensitizing agent (8-methoxypsoralen or 8-MOP) and UVA irradiation.
Mononuclear cells are harvested by an apheresis device usually and reinfused to the patient after cell irradiation.

Ref. XUV8501Q – Bag for U.V. treatment of blood cells

  • Nominal volume: 3 L
  • Connections: 1 spike, 1 injection site, 1 outlet port

Ref. 9MG2000 – Macogenic G2

  • Weight: 67 kg
  • Dimensions: 87 cm (width) x 64 cm (depth) x 38 cm (height)